Biomarkers mining for spinal cord injury based on integrated multi-transcriptome expression profile data.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
16 Apr 2021
Historique:
received: 01 01 2021
accepted: 02 04 2021
entrez: 17 4 2021
pubmed: 18 4 2021
medline: 6 10 2021
Statut: epublish

Résumé

This study was aimed to discover more biomarkers associated with spinal cord injury (SCI) by constructing a competing endogenous RNA (ceRNA) network. The transcriptome expression profile data related to SCI (GSE45006 GSE20907) were downloaded from GEO database. The differentially expressed RNAs (DERs), including lncRNAs, miRNAs, and mRNAs, between SCI and control groups were selected, which were then performed function enrichment analyses. Following that, a SCI-related ceRNA regulatory network was constructed. PCA analysis was performed on the genes constituting the ceRNA regulatory network directly related to SCI. In GSE45006 and GSE20907 datasets, there were respectively 3336 and 1453 DERs. Venn analysis showed that there were 429 DERs which had consistent differential expression direction. RGD1564534-miR-29b-5p relation pair and 103 miRNA-target regulatory pairs were integrated to construct the ceRNA regulatory network. Then a SCI-related ceRNA regulatory network including 8 mRNAs of IFNGR1, STAT2, CYBB, NFATC1, FCGR2B, HMOX1, TLR4, and HK2, a lncRNA of RGD1564534, and a miRNA of miR-29b-5p was constructed. Additionally, two pathways, osteoclast differentiation, and HIF-1 signaling pathway, were involved in this network. PCA indicated the samples before and after injury can be significantly distinguished based on the genes in the ceRNA network. A total of 8 SCI-related mRNAs have been identified in the ceRNA network, including IFNGR1, STAT2, CYBB, NFATC1, FCGR2B, HMOX1, TLR4, and HK2. Moreover, RGD1564534 may serve as ceRNA by competitively binding to miR-29b-5p to regulate the expression of 8 SCI-related mRNAs. Therefore, these genes may serve as key biomarkers of SCI.

Sections du résumé

BACKGROUND BACKGROUND
This study was aimed to discover more biomarkers associated with spinal cord injury (SCI) by constructing a competing endogenous RNA (ceRNA) network.
METHODS METHODS
The transcriptome expression profile data related to SCI (GSE45006 GSE20907) were downloaded from GEO database. The differentially expressed RNAs (DERs), including lncRNAs, miRNAs, and mRNAs, between SCI and control groups were selected, which were then performed function enrichment analyses. Following that, a SCI-related ceRNA regulatory network was constructed. PCA analysis was performed on the genes constituting the ceRNA regulatory network directly related to SCI.
RESULTS RESULTS
In GSE45006 and GSE20907 datasets, there were respectively 3336 and 1453 DERs. Venn analysis showed that there were 429 DERs which had consistent differential expression direction. RGD1564534-miR-29b-5p relation pair and 103 miRNA-target regulatory pairs were integrated to construct the ceRNA regulatory network. Then a SCI-related ceRNA regulatory network including 8 mRNAs of IFNGR1, STAT2, CYBB, NFATC1, FCGR2B, HMOX1, TLR4, and HK2, a lncRNA of RGD1564534, and a miRNA of miR-29b-5p was constructed. Additionally, two pathways, osteoclast differentiation, and HIF-1 signaling pathway, were involved in this network. PCA indicated the samples before and after injury can be significantly distinguished based on the genes in the ceRNA network.
CONCLUSION CONCLUSIONS
A total of 8 SCI-related mRNAs have been identified in the ceRNA network, including IFNGR1, STAT2, CYBB, NFATC1, FCGR2B, HMOX1, TLR4, and HK2. Moreover, RGD1564534 may serve as ceRNA by competitively binding to miR-29b-5p to regulate the expression of 8 SCI-related mRNAs. Therefore, these genes may serve as key biomarkers of SCI.

Identifiants

pubmed: 33863336
doi: 10.1186/s13018-021-02392-8
pii: 10.1186/s13018-021-02392-8
pmc: PMC8051034
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0
RNA, Long Noncoding 0
RNA, Messenger 0
Receptors, Interferon 0
STAT2 Transcription Factor 0
STAT2 protein, human 0
CYBB protein, human EC 1.6.3.-
NADPH Oxidase 2 EC 1.6.3.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

267

Références

J Neurosci. 2013 Dec 11;33(50):19664-76
pubmed: 24336730
Front Neurol. 2019 Jan 29;10:27
pubmed: 30761068
J Anat. 2004 Jan;204(1):3-11
pubmed: 14690473
Int J Clin Exp Pathol. 2015 Apr 01;8(4):3811-8
pubmed: 26097563
Surg Clin North Am. 2017 Oct;97(5):1031-1045
pubmed: 28958356
Arthritis Res. 2000;2(6):451-456
pubmed: 11094458
Integr Biol (Camb). 2016 Nov 7;8(11):1183-1193
pubmed: 27735002
Curr Neurovasc Res. 2018;15(3):211-219
pubmed: 29998804
Nucleic Acids Res. 2019 Jan 8;47(D1):D948-D954
pubmed: 30247620
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Cell Mol Biol Lett. 2019 Mar 14;24:11
pubmed: 30915127
J Phys Ther Sci. 2015 May;27(5):1429-33
pubmed: 26157234
Neural Regen Res. 2020 Apr;15(4):690-696
pubmed: 31638093
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Neural Regen Res. 2017 Mar;12(3):385-388
pubmed: 28469645
Acad Med. 2010 Mar;85(3):470-5
pubmed: 20182120
Elife. 2015 Aug 12;4:
pubmed: 26267216
J Neurosci. 2008 Apr 23;28(17):4322-30
pubmed: 18434510
J Gastrointestin Liver Dis. 2012 Mar;21(1):75-82
pubmed: 22457863
BMC Plant Biol. 2014 Jun 17;14:169
pubmed: 24939556
Development. 2008 Dec;135(23):3911-21
pubmed: 18997113
Nature. 2014 Jan 16;505(7483):344-52
pubmed: 24429633
Mol Med Rep. 2019 Apr;19(4):3021-3034
pubmed: 30816457
J Biopharm Stat. 2004 Aug;14(3):575-89
pubmed: 15468753
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Curr Med Res Opin. 2018 Jul;34(7):1217-1229
pubmed: 28952378
J Musculoskelet Neuronal Interact. 2015 Mar;15(1):32-41
pubmed: 25730650
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Scand J Rehabil Med. 1994 Dec;26(4):197-202
pubmed: 7878394
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5701-8
pubmed: 25337211
J Cereb Blood Flow Metab. 2013 Apr;33(4):524-31
pubmed: 23281425
J Neurotrauma. 2010 Feb;27(2):423-31
pubmed: 19891526
Genes Dev. 2010 May 15;24(10):992-1009
pubmed: 20413612
Neuroepidemiology. 2015;44(3):130-7
pubmed: 25896718
Genome Biol. 2010;11(8):R90
pubmed: 20799968
Int J Mol Sci. 2017 Apr 01;18(4):
pubmed: 28368292

Auteurs

Chongcheng Gong (C)

Emergency Trauma Surgery, Shanghai East Hospital of Tongji University, No. 150, Jimo Road, Shanghai, 200120, China.

Lin Liu (L)

Emergency Trauma Surgery, Shanghai East Hospital of Tongji University, No. 150, Jimo Road, Shanghai, 200120, China.

Yang Shen (Y)

Emergency Trauma Surgery, Shanghai East Hospital of Tongji University, No. 150, Jimo Road, Shanghai, 200120, China. shen2020yang@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH